Machine Learning Using Multiparametric Magnetic Resonance Imaging Radiomic Feature Analysis to Predict Ki-67 in World Health Organization Grade I Meningiomas.

BACKGROUND Although World Health Organization (WHO) grade I meningiomas are considered "benign" tumors, an elevated Ki-67 is one crucial factor that has been shown to influence tumor behavior and clinical outcomes. The ability to preoperatively discern Ki-67 would confer the ability to guide surgical strategy. OBJECTIVE In this study, we develop a machine learning (ML) algorithm using radiomic feature analysis to predict Ki-67 in WHO grade I meningiomas. METHODS A retrospective analysis was performed for a cohort of 306 patients who underwent surgical resection of WHO grade I meningiomas. Preoperative magnetic resonance imaging was used to perform radiomic feature extraction followed by ML modeling using least absolute shrinkage and selection operator wrapped with support vector machine through nested cross-validation on a discovery cohort (n = 230), to stratify tumors based on Ki-67 <5% and ≥5%. The final model was independently tested on a replication cohort (n = 76). RESULTS An area under the receiver operating curve (AUC) of 0.84 (95% CI: 0.78-0.90) with a sensitivity of 84.1% and specificity of 73.3% was achieved in the discovery cohort. When this model was applied to the replication cohort, a similar high performance was achieved, with an AUC of 0.83 (95% CI: 0.73-0.94), sensitivity and specificity of 82.6% and 85.5%, respectively. The model demonstrated similar efficacy when applied to skull base and nonskull base tumors. CONCLUSION Our proposed radiomic feature analysis can be used to stratify WHO grade I meningiomas based on Ki-67 with excellent accuracy and can be applied to skull base and nonskull base tumors with similar performance achieved.

[1]  D. Andrews,et al.  Resected WHO grade I meningioma and predictors of local control , 2021, Journal of Neuro-Oncology.

[2]  J. Barnholtz-Sloan,et al.  CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017. , 2020, Neuro-oncology.

[3]  Kaith K. Almefty,et al.  Prognostic value of the Simpson grading scale in modern meningioma surgery: Barrow Neurological Institute experience. , 2020, Journal of neurosurgery.

[4]  M. Berger,et al.  Multiplatform genomic profiling and magnetic resonance imaging identify mechanisms underlying intratumor heterogeneity in meningioma , 2020, Nature Communications.

[5]  Jacob S. Young,et al.  WHO Grade I Meningioma Recurrence: Identifying High Risk Patients Using Histopathological Features and the MIB-1 Index , 2020, Frontiers in Oncology.

[6]  W. Stummer,et al.  Risk of tumor recurrence in intracranial meningiomas: comparative analyses of the predictive value of the postoperative tumor volume and the Simpson classification. , 2020, Journal of neurosurgery.

[7]  J. Bartek,et al.  The Ki-67 Proliferation Index as a Marker of Time to Recurrence in Intracranial Meningioma. , 2020, Neurosurgery.

[8]  Si-ying Song,et al.  The prognostic role of Ki-67/MIB-1 in meningioma , 2020, Medicine.

[9]  Gabriel N Friedman,et al.  Predicting Discharge Disposition Following Meningioma Resection Using a Multiinstitutional Natural Language Processing Model , 2020, Journal of Neurological Surgery Part B: Skull Base.

[10]  S. Bakas,et al.  Imaging signatures of glioblastoma molecular characteristics: A radiogenomics review , 2020, Journal of magnetic resonance imaging : JMRI.

[11]  Sanjay Aneja,et al.  Applications of artificial intelligence in neuro-oncology. , 2019, Current opinion in neurology.

[12]  Christos Davatzikos,et al.  Precision diagnostics based on machine learning-derived imaging signatures. , 2019, Magnetic resonance imaging.

[13]  Christos Davatzikos,et al.  The Cancer Imaging Phenomics Toolkit (CaPTk): Technical Overview , 2019, BrainLes@MICCAI.

[14]  D. Dong,et al.  A deep learning radiomics model for preoperative grading in meningioma. , 2019, European journal of radiology.

[15]  Xuexi Zhang,et al.  Differentiation Researches on the Meningioma Subtypes by Radiomics from Contrast-Enhanced Magnetic Resonance Imaging: A Preliminary Study. , 2019, World neurosurgery.

[16]  Efstathios D. Gennatas,et al.  Integrated models incorporating radiologic and radiomic features predict meningioma grade, local failure, and overall survival , 2019, Neuro-oncology advances.

[17]  A. Hale,et al.  Machine learning analyses can differentiate meningioma grade by features on magnetic resonance imaging. , 2018, Neurosurgical focus.

[18]  David L Rimm,et al.  Ki67 reproducibility using digital image analysis: an inter-platform and inter-operator study , 2018, Laboratory Investigation.

[19]  Christos Davatzikos,et al.  In vivo evaluation of EGFRvIII mutation in primary glioblastoma patients via complex multiparametric MRI signature , 2018, Neuro-oncology.

[20]  A. Fathi Kazerooni,et al.  ADC‐derived spatial features can accurately classify adnexal lesions , 2018, Journal of magnetic resonance imaging : JMRI.

[21]  M. Karsy,et al.  Microvascularization of Grade I meningiomas: effect on tumor volume, blood loss, and patient outcome. , 2017, Journal of neurosurgery.

[22]  Christos Davatzikos,et al.  Cancer imaging phenomics toolkit: quantitative imaging analytics for precision diagnostics and predictive modeling of clinical outcome , 2018, Journal of medical imaging.

[23]  Raymond Y Huang,et al.  Radiographic prediction of meningioma grade by semantic and radiomic features , 2017, PloS one.

[24]  P. Lambin,et al.  Radiomics: the bridge between medical imaging and personalized medicine , 2017, Nature Reviews Clinical Oncology.

[25]  A. Berlin,et al.  Prognostic role of Ki-67 score in localized prostate cancer: A systematic review and meta-analysis. , 2017, Urologic oncology.

[26]  S. Torp,et al.  Significance of the Extent of Resection in Modern Neurosurgical Practice of World Health Organization Grade I Meningiomas. , 2017, World neurosurgery.

[27]  Prateek Prasanna,et al.  Co-occurrence of Local Anisotropic Gradient Orientations (CoLlAGe): A new radiomics descriptor , 2016, Scientific Reports.

[28]  G. Reifenberger,et al.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.

[29]  Luke Macyszyn,et al.  Imaging patterns predict patient survival and molecular subtype in glioblastoma via machine learning techniques. , 2016, Neuro-oncology.

[30]  A. Niemierko,et al.  Benign meningiomas (WHO Grade I) with atypical histological features: correlation of histopathological features with clinical outcomes. , 2016, Journal of neurosurgery.

[31]  Eun Hee Lee,et al.  Results of immunohistochemical staining for cell cycle regulators predict the recurrence of atypical meningiomas. , 2014, Journal of neurosurgery.

[32]  B. Yin,et al.  Correlating apparent diffusion coefficients with histopathologic findings on meningiomas. , 2012, European journal of radiology.

[33]  K. Kawai,et al.  Significance of Simpson grading system in modern meningioma surgery: integration of the grade with MIB-1 labeling index as a key to predict the recurrence of WHO Grade I meningiomas. , 2012, Journal of neurosurgery.

[34]  W. Vandertop,et al.  Impaired survival and long-term neurological problems in benign meningioma. , 2012, Neuro-oncology.

[35]  S. Uppin,et al.  Meningiomas: correlation of Ki67 with histological grade. , 2011, Neurology India.

[36]  O. Kim,et al.  Peritumoral brain edema in meningiomas : correlation of radiologic and pathologic features. , 2011, Journal of Korean Neurosurgical Society.

[37]  A. Sari,et al.  MIB-1 counting methods in meningiomas and agreement among pathologists. , 2008, Analytical and quantitative cytology and histology.

[38]  Alberto Orfao,et al.  Early recurrences in histologically benign/grade I meningiomas are associated with large tumors and coexistence of monosomy 14 and del(1p36) in the ancestral tumor cell clone. , 2007, Neuro-oncology.

[39]  J. Lafitte,et al.  Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis , 2004, British Journal of Cancer.

[40]  M. Samii,et al.  The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases , 2004, Acta Neurochirurgica.

[41]  J. Arends,et al.  MIB-1 labelling index is an independent prognostic marker in primary breast cancer. , 1998, British Journal of Cancer.

[42]  M. Jimbo,et al.  MIB‐1 staining index and peritumoral brain edema of meningiomas , 1996, Cancer.